Table 3.
Compliance | ||
---|---|---|
50% | 80% | |
ACE | 66.4% | 56.1% |
ARB | 68.1% | 57.0% |
β-blockers | 71.1% | 59.7% |
Spironolactone | 58.4%* | 45.6%* |
* Spironolactone versus ACE, ARB and β-blockers: p < 0.001 (Pearson's chi square test)
Compliance | ||
---|---|---|
50% | 80% | |
ACE | 66.4% | 56.1% |
ARB | 68.1% | 57.0% |
β-blockers | 71.1% | 59.7% |
Spironolactone | 58.4%* | 45.6%* |
* Spironolactone versus ACE, ARB and β-blockers: p < 0.001 (Pearson's chi square test)